The importance of infertility duration and follicle size according to pregnancy success in women undergoing ovulation induction with gonadotropins and intrauterine insemination. 2023

Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
University of Health Sciences Ankara City Hospital, Ankara, Turkey.

In this study, we aimed to evaluate the effect of infertility duration and dominant follicle size measured on the day of human chorionic gonadotropin (HCG) administration on pregnancy rates in infertile women undergoing ovulation induction (OI) with gonadotropin (GND). A total of 352 patients aged 20 to 41 years who were diagnosed with unexplained infertility or polycystic ovary syndrome (PCOS) were included in this study. Patients with a history of multifollicular development or follicle stimulating hormone (FSH) value more than 12 IU/ml were excluded from the study. The demographic and clinical features of the patients were obtained from the patients' files and hospital automation system and recorded for each woman. The demographic and clinical features of the patients were recorded. Patients were divided into two groups as live birth (group 1, n = 47) and non-live birth groups (group 2, n = 305). There were no statistically significant differences in regard to age, infertility type, follicle stimulating hormone (FSH) level, oestradiol (E2) level, antral follicle count (AFC), cycle characteristics, GND type, number of follicles, E2 level and endometrial thickness on HCG day, total GND dose, dominant follicle size (p > 0.05). Infertility duration in group 1 was 3.5 ± 2.1; in group 2, 4.7 ± 3.9 years. This difference was statistically significant (p = .014). According to this study, live birth rates after GND + IUIs(intrauterine insemination) were significantly affected by the duration of infertility. But the dominant follicle size and endometrial thickness measured on HCG day in GND and IUI cycles did not have a significant effect on pregnancy rates.IMPACT STATEMENTWhat is already known on the subject? It is thought that the timing of the ovarian triggering is vital for the success of intrauterine insemmination (IUI) treatment.What do the results of this study add? According to our results live birth rates after GND + IUIs were significantly affected by the duration of infertility.What are the implications of these findings for clinical practice and/or further research? It is determined that the duration of infertility is significant and patients should be encouraged to the treatment as soon as possible.

UI MeSH Term Description Entries
D007246 Infertility A reduced or absent capacity to reproduce. Sterility,Reproductive Sterility,Sterility, Reproductive,Sub-Fertility,Subfertility
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D007314 Insemination The deposit of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION. Inseminations
D007315 Insemination, Artificial Artificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION. Artificial Insemination,Eutelegenesis,Artificial Inseminations,Eutelegeneses,Inseminations, Artificial
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin
D006062 Gonadotropins Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities. Gonadotropin
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic

Related Publications

Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
August 2003, Fertility and sterility,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
September 2021, F&S reports,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
June 2015, Singapore medical journal,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
March 2012, Human fertility (Cambridge, England),
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
January 2022, Frontiers in endocrinology,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
March 2024, European journal of medical research,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
February 2020, Fertility and sterility,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
August 2006, Human reproduction (Oxford, England),
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
December 2003, Fertility and sterility,
Meryem Kuru Pekcan, and Aytekin Tokmak, and Hasan Ulubasoglu, and Mervenur Kement, and Gülnur Özakşit
April 2005, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!